Inicio | Buscar

Buscar

Resultados de la búsqueda

Efficacy and safety of CIMAvax-FOLFOX-BEVA in unresectable, left-sided, metastatic, colorectal cancer. Phase I/II

... Second Degree Specialist in Oncology Affiliation:  ... Santa Cruz More MD, First degree specialist in Clinical Oncology Villa Clara, Celestino ...

Clinical Trials - CIM - 12/01/2026 - 9:15am

Estudio para evaluar la preferencia de los pacientes y la satisfacción de la administración subcutánea de la combinación de dosis fija de Pertuzumab y Trastuzumab en participantes con cáncer de mama temprano positivo a HER2

... randomised multicentre, open-label, phase 2 trial. Lancet Oncology 2012;13(1):25-32. Gianni L, Pienkowski T, Im YH et al. 5-Year ... BO, Aft R et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Breast Cancer. Version I.2018 [internet]. ...

Ensayos Clínicos - ROCHE - 11/01/2026 - 6:13am

A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

... Medical Doctor, Second degree specialist in oncology Affiliation:  ... Havana, National Institute of Oncology and Radiobiology (INOR), Dr. Elías Gracia Medina, Medical Doctor, ...

Clinical Trials - ROCHE - 11/01/2026 - 6:13am

CIMAvax-EGF in Bladder cancer

... 1st Degree Specialist in Oncology Affiliation:  ... investigation. 5. Patients with an Eastern Cooperative Oncology Group (ECOG) performance status index ranging from 0 to 3. ...

Clinical Trials - CIM - 11/01/2026 - 6:06am

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

... Latin American Cooperative Oncology Group (LACOG) Primary ... Latin American Cooperative Oncology Group (LACOG) Source(s) of monetary ...

Clinical Trials - ROCHE - 11/01/2026 - 6:01am

Estudio para describir el diagnóstico, el tratamiento contra el cáncer y el resultado clínico en pacientes con cáncer de mama recién diagnosticado en América Latina

... Latin American Cooperative Oncology Group (LACOG) Promotor ... Latin American Cooperative Oncology Group (LACOG) Participación del ...

Ensayos Clínicos - ROCHE - 11/01/2026 - 6:00am

Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III.

... First Degree Specialist in Oncology Affiliation:  ...

Clinical Trials - CIM - 09/01/2026 - 6:43am

Biomodulin T-IM-oncological adults post chemotherapy-prevention COVID-19. Exploratory study

... National Institute of Oncology and Radiobiology (INOR). Department of Basic Research, Immunology ... National Institute of Oncology and Radiobiology (INOR) Postal ...

Clinical Trials - BIOCEN - 09/01/2026 - 6:22am

Biomodulina T-IM-adultos oncológicos post quimioterapia-prevención COVID-19. Estudio exploratorio

... for older adults: a Delphi consensus of geriatric oncology experts J Natl Compr Canc Netw, 13 (2015), pp. 1120-1130. 10. ...

Ensayos Clínicos - BIOCEN - 09/01/2026 - 6:21am

Phyisician Led CIMAvax-EGF lung biomarkers

... MD, First degree specialist in Oncology Affiliation:  ... Herrera Rodriguez, MD, Second Degree specialist in Oncology Matanzas, “Faustino ...

Clinical Trials - CIM - 08/01/2026 - 7:00am